Loading clinical trials...
Loading clinical trials...
A Randomised Double-blind Two-period Crossover Study to Investigate the Effect of Treatment With Repeat Doses of a PPAR Gamma Agonist on the Allergen-induced Late Asthmatic Response in Subjects With Mild Asthma Compared With Repeat Doses of Placebo
Conditions
Interventions
Rosiglitazone
Placebo
Locations
1
New Zealand
GSK Investigational Site
Wellington, New Zealand
Start Date
July 22, 2005
Primary Completion Date
June 30, 2006
Completion Date
June 30, 2006
Last Updated
September 25, 2017
NCT07486401
NCT07219173
NCT02327897
NCT04706988
NCT04639791
NCT06471257
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions